Cargando…

Low molecular weight heparin in COVID-19: benefits and concerns

Since its emergence, the COVID-19 pandemic had a dramatic impact on the public health worldwide and it scarred the medical, economical, and social determinants of health. Even after the significant vaccination advances, the disease of SARS-CoV-2 can manifest in severe presentations with life-threate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makarem, Adham, Zareef, Rana, Abourjeili, Joseph, Nassar, Joseph E, Bitar, Fadi, Arabi, Mariam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174321/ https://www.ncbi.nlm.nih.gov/pubmed/37180701 http://dx.doi.org/10.3389/fphar.2023.1159363

Ejemplares similares

Aspirin in COVID-19: Pros and Cons
por: Zareef, Rana, et al.
Publicado: (2022)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
por: Younis, Nour K., et al.
Publicado: (2020)

Corticosteroids in COVID-19: pros and cons
por: Bahsoun, Aymen, et al.
Publicado: (2023)

COVID-19 in congenital heart disease patients: what did we learn?!
por: Zareef, Rana, et al.
Publicado: (2023)

COVID-19 in Pediatric Patients: A Focus on CHD Patients
por: Zareef, Rana O., et al.
Publicado: (2020)

COVID-19: potential therapeutics for pediatric patients
por: Younis, Nour K., et al.
Publicado: (2021)

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
por: Paolisso, Pasquale, et al.
Publicado: (2020)

Tamponade and massive pleural effusions secondary to peripherally inserted central catheter in neonates–A complication to be aware of
por: Zareef, Rana, et al.
Publicado: (2023)

COVID-19 in Cyanotic Congenital Heart Disease
por: Ammar, Lama A, et al.
Publicado: (2023)

Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population
por: Abi Nassif, Tania, et al.
Publicado: (2021)

Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database
por: Liu, Leping, et al.
Publicado: (2023)

Pulmonary artery debanding in the cath lab: Lessons learned!
por: Zareef, Rana, et al.
Publicado: (2022)

Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl(4)-Induced Liver Fibrosis
por: Yan, Yishu, et al.
Publicado: (2017)

Case Report: Spontaneous Intramural Hematoma of the Colon Secondary to Low Molecular Weight Heparin Therapy
por: Zhu, Ye, et al.
Publicado: (2021)

The potential benefits of low-molecular-weight heparins in cancer patients
por: Robert, Francisco
Publicado: (2010)

Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials
por: Yang, Hui-qin, et al.
Publicado: (2021)

High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin
por: Asperti, Michela, et al.
Publicado: (2016)

Pathogenesis and distribution of infective endocarditis in the pediatric population: a 20-year experience in a tertiary care center in a developing country
por: Rashed, Moustafa, et al.
Publicado: (2023)

A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients
por: Giossi, Riccardo, et al.
Publicado: (2021)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
por: Perna, Alessandra F., et al.
Publicado: (2020)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

Low Molecular Weight Heparin Improves the Inflammatory State of Acute Sinusitis Rats Through Inhibiting the TLR4-MyD88-NF-κB Signaling Pathway
por: Wu, Tong, et al.
Publicado: (2021)

Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels
por: Bengalorkar, Girish M., et al.
Publicado: (2011)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

Use of low-molecular-weight heparin in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

The Effect of Low Molecular Weight Heparins on Fracture Healing
por: Kapetanakis, Stylianos, et al.
Publicado: (2015)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

Management of intentional overdose of low-molecular-weight heparin
por: Lu, Clara, et al.
Publicado: (2022)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
por: Taleja, Hitesh, et al.
Publicado: (2021)

Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions
por: Huang, Jing-Ning, et al.
Publicado: (2014)

Is the Incidence Trend of Heparin-Induced Thrombocytopenia Decreased by the Increased Use of Low-Molecular-Weight-Heparin?
por: Al-Eidan, Fahad A S
Publicado: (2015)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
por: Shute, Janis Kay
Publicado: (2023)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Update on the clinical use of the low-molecular-weight heparin, parnaparin
por: Camporese, Giuseppe, et al.
Publicado: (2009)

Diffuse alveolar hemorrhage associated with low molecular weight heparin
por: Hayashi, Shinichi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_msji8u1t5rh3nu895audo94q7s